MAIA Biotechnology, Inc. Earnings Per Share (Basic)
MAIA Biotechnology, Inc. (MAIA) reported Earnings Per Share (Basic) of -$0.13 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-10
- MAIA Biotechnology, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.13.
- MAIA Biotechnology, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.14.
- MAIA Biotechnology, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.10.
- MAIA Biotechnology, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.27.
- MAIA Biotechnology, Inc. earnings per share, basic for fiscal 2025 was -$0.70.
- MAIA Biotechnology, Inc. earnings per share, basic for fiscal 2024 was -$1.05.
- MAIA Biotechnology, Inc. earnings per share, basic for fiscal 2023 was -$1.49.
- MAIA Biotechnology, Inc. earnings per share, basic for fiscal 2022 was -$1.75.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.13 10-Q · filed 2026-08-10 | -$0.27 10-Q · filed 2026-08-10 | -$0.38 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$0.61 derived: net income ÷ weighted average shares · filed 2026-08-10 | ||
| 2026-03-31 | -$0.14 10-Q · filed 2026-05-11 | -$0.24 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$0.49 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$0.66 derived: net income ÷ weighted average shares · filed 2026-08-10 | ||
| 2025-12-31 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-03-23 | -$0.36 derived: net income ÷ weighted average shares · filed 2026-03-23 | -$0.53 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$0.70 10-K · filed 2026-03-23 | ||
| 2025-09-30 | -$0.27 10-Q · filed 2025-11-07 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$0.62 10-Q · filed 2025-11-07 | -$0.77 derived: net income ÷ weighted average shares · filed 2026-08-10 | ||
| 2025-06-30 | -$0.18 10-Q · filed 2026-08-10 | -$0.34 10-Q · filed 2026-08-10 | -$0.49 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$0.60 derived: net income ÷ weighted average shares · filed 2026-08-10 | ||
| 2025-03-31 | -$0.16 10-Q · filed 2026-05-11 | -$0.31 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$0.42 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$0.80 derived: net income ÷ weighted average shares · filed 2026-05-11 | ||
| 2024-12-31 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-03-23 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-03-23 | -$0.64 derived: net income ÷ weighted average shares · filed 2026-03-23 | -$1.05 10-K · filed 2026-03-23 | ||
| 2024-09-30 | -$0.11 10-Q · filed 2025-11-07 | -$0.50 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$0.93 10-Q · filed 2025-11-07 | -$1.31 derived: net income ÷ weighted average shares · filed 2025-11-07 | ||
| 2024-06-30 | -$0.40 10-Q · filed 2025-08-11 | -$0.85 10-Q · filed 2025-08-11 | -$1.26 derived: net income ÷ weighted average shares · filed 2025-08-11 | -$1.63 derived: net income ÷ weighted average shares · filed 2025-08-11 | ||
| 2024-03-31 | -$0.46 10-Q · filed 2025-05-09 | -$0.87 derived: net income ÷ weighted average shares · filed 2025-05-09 | -$1.23 derived: net income ÷ weighted average shares · filed 2025-05-09 | -$1.59 derived: net income ÷ weighted average shares · filed 2025-05-09 | ||
| 2023-12-31 | -$0.40 derived: net income ÷ weighted average shares · filed 2025-03-21 | -$0.76 derived: net income ÷ weighted average shares · filed 2025-03-21 | -$1.12 derived: net income ÷ weighted average shares · filed 2025-03-21 | -$1.49 10-K · filed 2025-03-21 | ||
| 2023-09-30 | -$0.36 10-Q · filed 2024-11-12 | -$0.71 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.08 10-Q · filed 2024-11-12 | -$1.46 derived: net income ÷ weighted average shares · filed 2024-11-12 | ||
| 2023-06-30 | -$0.35 10-Q · filed 2024-08-09 | -$0.72 10-Q · filed 2024-08-09 | -$1.10 derived: net income ÷ weighted average shares · filed 2024-08-09 | -$1.57 derived: net income ÷ weighted average shares · filed 2024-08-09 | ||
| 2023-03-31 | -$0.38 10-Q · filed 2024-05-14 | -$0.75 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$1.23 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$1.63 derived: net income ÷ weighted average shares · filed 2024-05-14 | ||
| 2022-12-31 | -$0.38 derived: net income ÷ weighted average shares · filed 2024-03-21 | -$0.86 derived: net income ÷ weighted average shares · filed 2024-03-21 | -$1.26 derived: net income ÷ weighted average shares · filed 2024-03-21 | -$1.75 10-K · filed 2024-03-21 | ||
| 2022-09-30 | -$0.48 10-Q · filed 2023-11-07 | -$0.49 10-Q · filed 2022-11-09 | -$0.89 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.39 10-Q · filed 2023-11-07 | -$1.40 10-Q · filed 2022-11-09 | -$1.80 derived: net income ÷ weighted average shares · filed 2023-11-07 |
| 2022-06-30 | -$0.40 10-Q · filed 2023-08-08 | -$0.90 10-Q · filed 2023-08-08 | -$1.31 derived: net income ÷ weighted average shares · filed 2023-08-08 | -$2.17 derived: net income ÷ weighted average shares · filed 2023-08-08 | ||
| 2022-03-31 | -$0.50 10-Q · filed 2023-05-08 | -$0.91 derived: net income ÷ weighted average shares · filed 2023-05-08 | -$1.79 derived: net income ÷ weighted average shares · filed 2023-05-08 | |||
| 2021-12-31 | -$0.41 derived: net income ÷ weighted average shares · filed 2023-03-24 | -$1.32 derived: net income ÷ weighted average shares · filed 2023-03-24 | -$2.37 10-K · filed 2023-03-24 | |||
| 2021-09-30 | -$1.02 10-Q/A · filed 2023-02-06 | -$2.06 10-Q/A · filed 2023-02-06 | ||||
| 2021-06-30 | -$0.78 10-Q · filed 2022-08-22 | -$1.01 10-Q · filed 2022-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |